SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 121 filers reported holding SUTRO BIOPHARMA INC in Q2 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $7,401,069 | -25.4% | 2,132,873 | 0.0% | 0.03% | -23.8% |
Q2 2023 | $9,917,859 | +0.6% | 2,132,873 | 0.0% | 0.04% | -12.5% |
Q1 2023 | $9,853,873 | -47.3% | 2,132,873 | -7.8% | 0.05% | -57.9% |
Q4 2022 | $18,693,419 | +20.1% | 2,313,542 | -17.5% | 0.11% | +15.2% |
Q3 2022 | $15,569,000 | +6.5% | 2,805,197 | 0.0% | 0.10% | +12.5% |
Q2 2022 | $14,615,000 | -2.9% | 2,805,197 | +53.1% | 0.09% | +12.8% |
Q1 2022 | $15,057,000 | -36.1% | 1,831,755 | +15.7% | 0.08% | -36.6% |
Q4 2021 | $23,564,000 | -22.4% | 1,583,579 | -1.5% | 0.12% | -25.5% |
Q3 2021 | $30,365,000 | +2.3% | 1,607,466 | +0.7% | 0.16% | -1.8% |
Q2 2021 | $29,686,000 | -8.4% | 1,596,882 | +12.2% | 0.17% | -17.2% |
Q1 2021 | $32,392,000 | +39.8% | 1,423,205 | +33.4% | 0.20% | +39.0% |
Q4 2020 | $23,170,000 | – | 1,067,258 | – | 0.15% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Samsara BioCapital, LLC | 1,675,579 | $13,773,000 | 3.47% |
AJU IB Investment Co., Ltd. | 175,000 | $1,439,000 | 2.22% |
Frazier Life Sciences Management, L.P. | 1,776,479 | $14,603,000 | 1.24% |
First Light Asset Management, LLC | 1,672,497 | $13,748,000 | 1.21% |
BVF INC/IL | 3,447,946 | $28,342,000 | 1.13% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 3,732,400 | $30,680,000 | 0.94% |
Endurant Capital Management LP | 296,508 | $2,437,000 | 0.64% |
Parkman Healthcare Partners LLC | 199,846 | $1,643,000 | 0.48% |
Eventide Asset Management | 2,708,975 | $22,268,000 | 0.35% |
Lombard Odier Asset Management (Switzerland) SA | 391,024 | $3,214,000 | 0.25% |